Navigation Links
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Date:5/21/2013

clinical study of a drug formulation that we have wholly created and developed in-house using our unique particle engineering technology and Respiratory Medicine by Design approach. This important milestone, along with the planned EU filing of our lead product PSX1001 in the first half of 2014, highlights the rapid progress that Prosonix is making, and the significant value we are generating for all our stakeholders who have backed our respiratory focused strategy in mono and combination products."

About COPD

COPD is a long term, progressively destructive and life-threatening disease of the lungs, generally caused by cigarette smoking. The most common symptoms of COPD are breathlessness, production of abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough. Performance of everyday activities may be severely curtailed and overall quality of life significantly impaired. COPD is not curable, but treatment ameliorates symptoms and may slow the progress of the disease.

According to the World Health Organization, approximately 65 million people worldwide had COPD in 2004 and it is predicted to become the third leading cause of death by 2020. A limited number of mono and combination therapies are approved for this indication and together these products generated sales of more than $8 billion in 2011 in the seven major markets. LAMAs accounted for approximately $3 billion in sales from this total and Datamonitor (November 2011, HC000218) estimates that sales of this class of product will remain stable through 2020.

Further details about the study

The randomised, double-blind, single-dose study will investigate the effects on expiratory lung function, tolerability and safety of a range of doses of orally inhaled PSX1002 vs placebo delivered via pressurised metered dose inhaler (pMDI) in up to 40 male and female patients diagnosed with moderate or severe COPD.

The primary endpoint of the study is imp
'/>"/>

SOURCE Prosonix
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
2. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
3. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
4. Applied Genetics Initiates Commercial Operation
5. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
6. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
7. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
8. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
9. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
10. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
11. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... (PRWEB) July 11, 2014 BCC Research ... DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS ... (PCR) technology reached nearly $140 billion in 2013. This ... registering a five-year compound annual growth rate (CAGR) of ... number of interesting and exciting possibilities within the broader ...
(Date:7/10/2014)... Faso (PRWEB) July 10, 2014 ... today have access to an additional family planning ... access to contraception at all levels of the ... lower-dose formulation of a widely used contraceptive—Pfizer’s Depo-Provera® ... , Burkina Faso is the first of four ...
(Date:7/10/2014)... Francisco, CA (PRWEB) July 10, 2014 ... family closer together. The Archer Family purchased a ... contained within DNA, but ended up with a lifetime ... discoveries contained within the family members’ DNA genuinely brought ... had decided to search deeper into genetic history and ...
(Date:7/10/2014)... CROWN POINT, Ind. , July 10, ... recently expanded its use of capnography for ... a growing group of healthcare leaders in ... Capnography measures how effectively patients are breathing ... respiratory depression occurs. By measuring the amount ...
Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... - Rayovac and Sanyo have announced ... capacities and shorter charging times. , ,Sanyo will be working ... Nickel Metal Hydride, or NiMH, batteries in 15 minutes. I-C3, ... pressure control in each battery to regulates the charging mechanism, ...
... Wave Technologies Inc. and Innogenetics NV ... agreement. Under the terms of the agreement, Third ... marketing and distribution rights for select Invader molecular ... effort to penetrate the growing European molecular diagnostics ...
... visits the University of Wisconsin-Eau Claire campus for ... up her newly earned Master of Business Administration degree. , ... 11 UW-Eau Claire students to earn their MBAs completely online. ... her first real look at the campus and her first ...
Cached Biology Technology:Third Wave lands European distribution deal, reports high earnings 2UW-Eau Claire graduates first online MBAs 2UW-Eau Claire graduates first online MBAs 3
(Date:7/14/2014)... depleting our arsenal against deadly diseases and infections, ... research shows promise to speed up the drug ... ACS Chemical Biology , University of Illinois ... novel, medically relevant products produced by bacteria. , ... to find a novel product, said principal investigator ...
(Date:7/14/2014)... control insect body size? What influence does genetics have on ... Current Opinion in Insect Science launched today ... Current Opinion in Insect Science is the latest title ... journal that aims to provide specialists with a unique platform ... in the field of insect science. First articles published are ...
(Date:7/14/2014)... local environment manage much better in the struggle for ... , A world without bees would be a whole ... 600 million to 1 billion Danish kroner are earned ... honey and pollinating a wide range of crops from ... over the world are under pressure from pesticides, mites, ...
Breaking Biology News(10 mins):Innovative technique may transform the hunt for new antibiotics and cancer therapies 2Innovative technique may transform the hunt for new antibiotics and cancer therapies 3Best for bees to be stay-at-homes 2
... SANTA CRUZ, CA--The emerging field of "personalized" or ... cancer. If scientists can identify the genetic changes that ... information to develop targeted treatments. But achieving this goal ... and a sophisticated infrastructure to manage and analyze the ...
... Lewin has been elected to the National Academy of Sciences ... in the Department of Animal Sciences and founding director of ... he conducted during his 27 years at the University of ... University of California, Davis, where he earned his doctorate in ...
... 1, 2012)A recent study published in the May/June 2012 ... journal of the Academy of General Dentistry, found that ... energy drinks, especially among adolescents, is causing irreversible damage ... erode tooth enamel, the glossy outer layer of the ...
Cached Biology News:UC Santa Cruz builds national data center for cancer genome research 2UC Santa Cruz builds national data center for cancer genome research 3UC Santa Cruz builds national data center for cancer genome research 4UC Santa Cruz builds national data center for cancer genome research 5Harris Lewin elected to National Academy of Sciences 2Sports and energy drinks responsible for irreversible damage to teeth 2
Recalibration of HL-2000-CAL products...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
LAL Chromogenic Endpoint assay...
...
Biology Products: